Tobacco Use Disorder (TUD)

Claire Willman


Background 

  • All patients should be screened for nicotine use (smoking, chewing, and vaping of nicotine containing products).
  • Nicotine withdrawal is one of the most common reasons that patients leave the hospital before medically advised.
  • Hospitalized patients receiving pharmacotherapy for nicotine use have higher rates of cessation.

Management 

  • Combination therapy is superior to single therapy alone.
  • Nicotine Replacement Therapy.
  • Basal:
    • Transdermal nicotine patch provides sustained levels of nicotine.
    • > 10 cigarettes (1/2 pack) per day: 21 mg patch.
    • < 10 cigarettes (1/2 pack) per day: 14 mg patch.
    • Remove overnight, abnormal dreams and nightmares are a common if not removed.
  • Bolus
    • Gum/ Lozenge provides immediate nicotine for breakthrough cravings.
    • First cigarette within 30 minutes of waking: 4 mg gum/lozenge.
    • First cigarette after 30 minutes of waking: 2 mg gum/lozenge.
  • Patients smoking 1+ packs per day will likely still require 4 mg gum/lozenge.
  • Order q1h PRN as patients will titrate utilization as they would with their outpatient nicotine.
  • Chew and park method for nicotine gum; sublingual absorption needed to bypass first metabolism.
  • Other medications:
    • Varenicline
      • Equivalent efficacy to combination NRT for smoking cessation.
      • Limited utility in the inpatient setting due to side effect tolerability and need for dose titration over multiple days.
    • Bupropion
      • Effective but less efficacious than combination NRT and varenicline.
      • Limited utility in the inpatient setting due to dose titration over a week and delay in steady state blood levels.
      • Contraindicated in those with seizure disorder and those at risk of seizures.

Last updated on